NYSE · HLF

Herbalife Ltd.

$11.89 +$0.09 (+0.76%) 1D After hours

Key Metrics

$1.22B
Market cap
5.10×
P/E · TTM
$5.13B
Revenue · TTM
$239.80M
Net income
EPS · TTM $2.35
Dividend yield
Free cash flow $373.90M
Beta · 1Y 1.28
EBITDA · TTM
Gross margin 77.8%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 9
    From its Feb 20 high, the share price fell 43%.

    Peak close $19.96 on Feb 20; trough close $11.30 on Jun 9. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -43%
  • May 7
    The stock moved -11.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 7
  • Feb 19
    The stock moved +18.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 19

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$1.22B
Enterprise value$2.76B
Shares outstanding103.7M
52-wk range$7.56 – $20.40
Avg volume · 20D1.6M
Net cash −$1.54B
Book value / share$-4.32
IndustryWholesale-Drugs, Proprietaries & Druggists' Sundries
ExchangeNYSE
About Herbalife Ltd.
IPO dateDec 16, 2004
Employees8500

Herbalife Ltd is a health and wellness company. It provides health and wellness products in 95 markets through a direct-selling business model. Its product categories include Weight Management, Targeted Nutrition, Energy, Sports and Fitness, Outer Nutrition, and Literature, Promotional, and Other.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E5.10
P/S0.24
P/FCF3.27
EV/EBITDA
EV/Sales0.54
Graham №

Profitability

Gross 77.8%
Operating 5.8%
Net 4.7%
FCF 7.3%
ROE / ROIC -38.6% · 21.7%

Financial Health

Current ratio1.23
Quick ratio0.74
Debt / equity-4.51
Debt / EBITDA
Net cash −$1.54B
Working capital$230.00M

Cash Flow · TTM

Operating CF $446.90M
Capex −$73.00M
Free cash flow $373.90M
Buybacks $6.70M
Dividends paid
Shareholder yield 0.5%

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

2.2
Grey zone (1.81–2.99) · monitor

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings